Extended lymphadenectomy to increase perioperative risks in Muscle-Invasive Bladder Cancer
Yüksel Ürün posted on X:
“Extended lymphadenectomy did not improve survival but increased perioperative risks in Muscle-Invasive Bladder Cancer.
- 5-year disease-free survival: Extended 56% vs Standard 60%
- Overall survival: E 59% vs S 63%
- Mortality within 90 days: Extended 7%, Standard 2%.
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer
Authors: Seth P. Lerner, Catherine Tangen, Robert S. Svatek, Siamak Daneshmand, Kamal S. Pohar, Eila Skinner, Anne Schuckman, Arthur I. Sagalowsky, Norm D. Smith, Ashish M. Kamat, Wassim Kassouf, Melissa Plets, Rick Bangs, Theresa M. Koppie, Ajjai Alva, Francisco G. La Rosa, Sumanta K. Pal, Adam S. Kibel, Daniel J. Canter, Ian M. Thompson.”
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023